Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flow from operating activities:
Net loss	$ (11,136)	$ (10,875)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	3,430	3,532
Amortization	1,182	1,448
Provision for doubtful accounts receivable	401	162
Common stock and share-based compensation, options	1,161	1,475
Impairment of intangibles and property	1,069	1,592
Change in fair value of derivative warrant and conversion liabilities	(5,420)	(332)
Loss on extinguishment	4,941	0
Financing expense	2,184	0
Recovery from former customer	0	(1,000)
Settlement with former officer	0	(267)
Deferred tax benefit	(1,935)	(345)
Foreign exchange loss	617	0
Other	158	772
Changes in operating assets and liabilities:
Accounts receivable	(462)	(577)
Inventories	201	343
Accounts payable and accrued expenses	215	517
Pre-petition liabilities	(1,615)	(4,790)
Other	187	(807)
Net cash used in operating activities	(4,822)	(9,152)
Cash flows from investing activities:
Receipts on notes receivable	700	1,100
Proceeds from sales of property	576	0
Purchases of property	(6,482)	(6,867)
Restricted cash	200	(200)
Other	44	(210)
Net cash used in investing activities	(4,962)	(6,177)
Cash flows from financing activities:
Proceeds from sale of membership interests in Nutra SA, net of costs	1,500	11,625
Proceeds from issuance of convertible debt and related warrants	3,563	506
Payments of debt	(12,610)	(8,818)
Proceeds from issuance of debt	15,189	15,056
Net cash provided by financing activities	7,642	18,369
Effect of exchange rate changes on cash and cash equivalents	(147)	(248)
Net change in cash and cash equivalents	(2,289)	2,792
Cash and cash equivalents, beginning of year	3,329	537
Cash and cash equivalents, end of year	1,040	3,329
Supplemental disclosures:
Cash paid for interest	1,651	1,551
Cash paid for income taxes	$ 0	$ 0